Document Detail


Immunology and personalized medicine in oncology.
MedLine Citation:
PMID:  24966077     Owner:  NLM     Status:  Publisher    
Abstract/OtherAbstract:
The comprehension of "what cancer is" was bespoke these two last decades, switching from the traditional centro-cellular vision of cancer to a new holistic vision which integrates the tumor microenvironment and its immune component. Although in both visions, the result is, in fine, the emergence of a clone of cancer cells whose genome is modified, the genesis of the emergence of this clone and of its expansion is quite different offering a new explanatory framework and allowing the design of new predictive bio-markers as well as the development of innovative therapies. Recent data demonstrate that the immune infiltrate of the tumor is determinant for the outcome of patients bearing a solid cancer. For the first time, patient' prognosis can be estimated, not only by the assessment of tumor criteria (TNM classification, genetic disorders) but also by the evaluation of the immune component of the tumor microenvironment, using novel methodologies such as the 'Immunoscore'. Taking account of parameters derived from the reaction of the host against his tumor is an additional step towards a so-called Personalized Medicine in patients with cancer.
Authors:
Franck Zinzindohoué; Guy Zeitoun; Anne Berger; Ana-Maria Todosi; Florence Marliot; Christine Lagorce; Jérôme Galon; Franck Pagès
Related Documents :
11344077 - Benign lesions of the frontal sinus.
16631697 - Cavo-atrial tumor resection under total circulatory arrest without a sternotomy.
23332407 - Abr in the diagnosis of vestibular schwannomas: a meta-analysis.
1703637 - Follow-up study on metastatic cerebellar tumor surgery--characteristic problems of surg...
16424687 - Intracardiac extension of lung cancer demonstrated on pet scanning.
6408567 - Patterns of nutritional deficiency in head and neck cancer.
Publication Detail:
Type:  JOURNAL ARTICLE    
Journal Detail:
Title:  Bulletin du cancer     Volume:  101     ISSN:  1769-6917     ISO Abbreviation:  Bull Cancer     Publication Date:  2014 Jun 
Date Detail:
Created Date:  2014-6-26     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  0072416     Medline TA:  Bull Cancer     Country:  -    
Other Details:
Languages:  ENG     Pagination:  12-17     Citation Subset:  -    
Vernacular Title:
Place de l'immunologie dans la médecine personnalisée en cancérologie.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Biological markers in haematological malignancies.
Next Document:  Biological network modelling and precision medicine in oncology.